This article was originally published on TipRanks.com Bristol Myers Squibb (NYSE: BMY) revealed that it has bagged approval from the U.
Global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) has started an accelerated share repurchase to buy back shares worth $5 billion. Following the …
This article was originally published on TipRanks.com Pharmaceutical company Bristol Myers Squibb (NYSE: BMY) has reported mixed results for the quarter ended December 31, 2021.
This article was originally published on TipRanks.com Biotechnology company Regeneron Pharmaceuticals, Inc.
This article was originally published on TipRanks.com Global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) announced that it has received a positive Committee …
This article was originally published on TipRanks.com Bristol Myers (BMY) has entered into a license, development, and commercialization agreement with clinical-stage biopharmaceutical company …
This article was originally published on TipRanks.com The Board of Directors of Bristol Myers Squibb (BMY) has approved an increment to the quarterly …
Bristol Myers Squibb (BMY) announced that it has received a Marketing Authorization from the European Commission (EC) for Zeposia (ozanimod) for the treatment of adults with moderately …
During a Late-Breaking Science session at the American Heart Association (AHA) Scientific Sessions 2021, Bristol Myers Squibb (BMY) and Janssen Pharmaceuticals, a Johnson and Johnson (JNJ) company, …
American pharmaceutical industry company Bristol Myers Squibb (BMY) has posted better-than-expected earnings for the third quarter of 2021. However, revenues missed analysts’ expectations.
